hhs-20260521

___________________________________________________

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

___________________________________________________

(Exact Name of Registrant as Specified in its Charter)

___________________________________________________


Delaware	1-7120	74-1677284
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification Number)

(Address of principal executive offices and Registrant’s telephone number, including area code)

___________________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock	HHS	NASDAQ

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 5.07 Submission of Matters to a Vote of Security Holders

Harte Hanks, Inc. (the “Company”) held the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on May 21, 2026, at which stockholders voted on the items below as indicated.

I.Election of four (4) Board nominees, each to serve until our 2026 annual meeting of stockholders or until their successors are duly elected and qualified:


Nominees	For		Withhold	Broker Non-Votes
Genni Combes	4,892,543		230,625	394,667
John H. Griffin, Jr.	4,887,154		236,014	394,667
Bradley Radoff	5,074,650	48,518	48,518	394,667
Elizabeth Ross	5,060,960		62,208	394,667

II. To approve (on a non-binding advisory basis) the compensation of our named executive officers:


For	Against	Abstain	Broker Non-Votes
4,875,115	246,517	1,536	394,667

III. To consider and vote upon the ratification of the selection of Wolf & Company P.C. as Harte Hanks’ independent registered public accounting firm for the fiscal year ended December 31, 2026:


For	Against	Abstain	Broker Non-Votes
5,506,650	7,581	3,604	—

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	HARTE HANKS, INC.


Date: May 21, 2026	By:	/s/ David Garrison
		David Garrison Chief Financial Officer